Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Liposkin is a topical medical device product line developed by Dalyn for the management of acne-prone skin and acne vulgaris. The most prominent formulation, Liposkin Mask, is a peel-off medical device that utilizes polyvinyl alcohol to create a semi-occlusive mechanical barrier on the skin's surface. This barrier facilitates the deep penetration of its active constituents, primarily nicotinamide (niacinamide) and gluconolactone. Nicotinamide provides anti-inflammatory properties and helps regulate sebum production by modulating sebaceous gland activity, while gluconolactone, a polyhydroxy acid (PHA), acts as a gentle keratolytic exfoliant and humectant. The combination is designed to reduce comedones and inflammatory lesions while restoring the skin's physiological balance and barrier function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Liposkin.